The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

AIM WINNERS & LOSERS: Polarean Imagaing jumps on US FDA approval

Wed, 28th Dec 2022 09:53

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Polarean Imaging PLC, up 35% at 66.25 pence, 12-month range 37.28p - 84.20p. Secures approval from the US Food & Drug Administration for its drug device combination product, Xenoview, for evaluation of lung ventilation in adults and paediatric patients aged 12 years and older. Polarean Chief Executive Richard Hullihen says: "Approval of Xenoview represents a major step forward in modern respiratory imaging and we are proud to have pioneered this exciting new technology for clinical use. The commercial team at Polarean is prepared to rapidly launch Xenoview for clinical application."

----------

Applied Graphene Materials PLC, up 9.7% at 5.49 pence, 12-month range 3.00p - 28.00p. Confirms that non-binding indicative proposals have been received from interested parties for the sale of its trade and assets, or of the shares in, its main operating subsidiary. Says it is in discussions with the parties involved with a view to gaining final proposals in early January. After this, the board would then select a preferred party to progress with. Adds there can be no certainty any final proposals will be made, nor the terms any proposals may be made.

----------

AIM - LOSERS

----------

Trafalgar Property Group PLC, down 4.9% at 0.16 pence, 12-month range 0.15p - 1.20p. Interim loss widens as revenue falls sharply and costs increase. In the six months to September 30, pretax loss widens to GBP444,000 from GBP338,000. Revenue drops to GBP18,000 from GBP390,000, and administrative expenses increase 48% to GBP380,000 from GBP257,000. Chief Executive Paul Treadaway says: "Reflecting on the issues of the previous two years in the economy and the challenges businesses and consumers have faced, the directors have considered relevant information including the current cost-of-living crisis, higher interest rates and even higher inflation, which are driving a challenging market and have performed a robust analysis of future cash flows."

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2022 Alliance News Ltd. All Rights Reserved.

Related Shares

More News
10 May 2024 12:00

LONDON MARKET MIDDAY: FTSE 100 hits record high on BoE vote, UK GDP

(Alliance News) - Stock prices in London were up at midday on Friday, hitting a record high once again as investors reacted positively to a dovish Ban...

10 May 2024 11:57

Polarean shares jump on MRI system order

(Sharecast News) - Advanced MRI technology specialist Polarean Imaging shares were surging on Friday, after receiving its second de novo order for a n...

10 May 2024 11:40

Polarean shares soar on University of Alabama deal for Xenon MRI

(Alliance News) - Polarean Imaging PLC on Friday said it has received its second de novo order for a new Xenon MRI system from the University of Alaba...

10 May 2024 10:59

AIM WINNERS & LOSERS: Polarean wins deal; Genedrive completes placing

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

3 May 2024 15:40

IN BRIEF: Polarean Imaging wins order for new polariser

Polarean Imaging PLC - London-based medical imaging technology developer - Receives an order for a new polariser to replace the research polariser at ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.